Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.74, $0.07 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $11.1 billion versus the consensus estimate of $11.11 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of $7.48.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.